Regulatory News
Sunday, November 13, 2016
BRIEF-Impedimed Ltd to commence full commercial launch of l- dex in oncology in U.S.
* Poised to commence full commercial launch of l-dex in
oncology in U.S.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment